The role of neuromodulation in heart failure with preserved ejection fraction
- 11 October 2025
- journal article
- review article
- Published by Elsevier in Current Problems in Cardiology
- Vol. 50 (12) , 103189
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection FractionJAMA Cardiology, 2024
- Unraveling the complex pathophysiology of heart failure: insights into the role of renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system (SNS)Current Problems in Cardiology, 2024
- Autonomic regulation therapy in chronic heart failure with preserved/mildly reduced ejection fraction: ANTHEM-HFpEF study resultsInternational Journal of Cardiology, 2023
- Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection FractionJACC: Basic To Translational Science, 2021
- Surgical ablation of the right greater splanchnic nerve for the treatment of heart failure with preserved ejection fraction: first‐in‐human clinical trialEuropean Journal of Heart Failure, 2021
- Autonomic Neuromodulation Acutely Ameliorates Left Ventricular Strain in HumansJournal of Cardiovascular Translational Research, 2018
- Renal Denervation in Heart Failure with Preserved Ejection Fraction (RDT-PEF): A Randomized Controlled TrialEuropean Journal of Heart Failure, 2016
- The Role of Renal Denervation in the Treatment of Heart FailureCurrent Cardiology Reports, 2012
- Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant HypertensionJACC, 2011
- Chronic Baroreflex Activation: A Potential Therapeutic Approach to Heart Failure With Preserved Ejection FractionJournal of Cardiac Failure, 2011